Dow Jones

40,211.72

0.53%

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

(MM) (IDIX)

(MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IDIX

<< Previous 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Next >>

Date	Time	Source	Headline	Symbol	Company
05/01/2011	21:05	PR Newswire (US)	Idenix Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference	NASDAQ:IDIX	(MM)
30/12/2010	13:01	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:IDIX	(MM)
06/12/2010	21:07	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:IDIX	(MM)
26/11/2010	12:49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDIX	(MM)
23/11/2010	21:09	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:IDIX	(MM)
23/11/2010	13:00	PR Newswire (US)	Idenix Pharmaceuticals Announces $20 Million Milestone Payment From ViiV Healthcare for Initiation of Phase IIb Trial of '761	NASDAQ:IDIX	(MM)
02/11/2010	20:06	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:IDIX	(MM)
01/11/2010	20:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDIX	(MM)
01/11/2010	19:12	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:IDIX	(MM)
29/10/2010	21:15	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:IDIX	(MM)
29/10/2010	21:05	PR Newswire (US)	Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2010 Financial Results	NASDAQ:IDIX	(MM)
28/10/2010	14:00	PR Newswire (US)	Idenix Pharmaceuticals Announces Ronald C. Renaud, Jr. Named President, Chief Executive Officer and Member of the Board of Direc	NASDAQ:IDIX	(MM)
27/10/2010	21:05	PR Newswire (US)	Idenix Pharmaceuticals to Hold an Investor/Analyst Day Event on October 30, 2010	NASDAQ:IDIX	(MM)
26/10/2010	21:05	PR Newswire (US)	Idenix Pharmaceuticals to Present at an Upcoming Investor Conference	NASDAQ:IDIX	(MM)
13/10/2010	21:31	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:IDIX	(MM)
13/10/2010	21:09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDIX	(MM)
13/10/2010	21:07	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:IDIX	(MM)
01/10/2010	14:55	PR Newswire (US)	Idenix Announces Data Presentations at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASL	NASDAQ:IDIX	(MM)
20/09/2010	21:17	PR Newswire (US)	Idenix Pharmaceuticals to Present at Four Upcoming Investor Conferences	NASDAQ:IDIX	(MM)
16/09/2010	19:37	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/A)	NASDAQ:IDIX	(MM)
07/09/2010	21:05	PR Newswire (US)	Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences	NASDAQ:IDIX	(MM)
07/09/2010	13:03	Dow Jones News	Idenix Says FDA Put Studies Of Hepatitis C Drug On Hold	NASDAQ:IDIX	(MM)
07/09/2010	12:01	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:IDIX	(MM)
07/09/2010	12:00	PR Newswire (US)	Idenix Provides Update on HCV Clinical Development Activities	NASDAQ:IDIX	(MM)
23/08/2010	19:49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDIX	(MM)
13/08/2010	21:36	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:IDIX	(MM)
27/07/2010	21:05	PR Newswire (US)	Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences	NASDAQ:IDIX	(MM)
27/07/2010	17:15	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:IDIX	(MM)
26/07/2010	21:22	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:IDIX	(MM)
26/07/2010	21:05	PR Newswire (US)	Idenix Pharmaceuticals Reports Second Quarter 2010 Financial Results and Provides Research and Development Update on HCV Program	NASDAQ:IDIX	(MM)